Disclosure of Invention
The embodiment of the invention provides a chemiluminescence detection kit for S100B protein, which is used for meeting the clinical detection requirement and realizing quantitative detection of S100B protein in serum more quickly and accurately.
The chemiluminescence detection kit for the S100B protein provided by the embodiment of the invention comprises: the kit comprises an ELISA plate coated with an anti-S100B monoclonal antibody, an anti-S100 polyclonal antibody solution for detecting horseradish peroxidase labeling, a standard product diluent, a sample diluent, a concentrated washing solution, a luminescent solution A, a luminescent solution B and a detection antibody diluent.
The embodiment of the invention also provides a use method of the chemiluminescence detection kit for the S100B protein, which comprises the following steps:
(1) the following solutions were prepared:
diluting a detection anti-S100 polyclonal antibody solution marked by horseradish peroxidase by using a detection antibody diluent, wherein the ratio of the detection anti-S100 polyclonal antibody solution marked by horseradish peroxidase to the detection antibody diluent is 1: 10000;
diluting a detection anti-S100 polyclonal antibody solution marked by horseradish peroxidase by using a detection antibody diluent, wherein the volume ratio of the detection anti-S100 polyclonal antibody marked by the horseradish peroxidase to the detection antibody diluent is 1:5000, so as to obtain an enzyme conjugate;
dissolving a standard substance by using a standard substance diluent to obtain a plurality of standard substance solutions with gradient changes in concentration;
and diluting the concentrated washing solution with distilled water or deionized water according to the volume ratio of 1:20 to obtain the washing solution.
(2) Drawing a standard curve:
respectively adding 50 mu L of calibrator solution into corresponding holes of an ELISA plate coated with the anti-S100B monoclonal antibody, then respectively adding 100 mu L of horseradish peroxidase-labeled anti-S100 polyclonal antibody solution for detection into each hole, and lightly shaking and uniformly mixing;
sealing the plate with a sealing plate film, then incubating for 2 hours at 37 ℃, fully washing for 5 times with the washing solution, and drying;
adding 25 mu L of luminous liquid A, B into each hole, and lightly shaking and uniformly mixing;
adjusting the zero point by using a blank hole, and measuring the optical density value of each hole by using a luminometer;
performing data processing by using a log-log linear fitting mode, and drawing by using the log of the optical density value of each calibrator as a vertical coordinate and the log of the concentration of each calibrator as a horizontal coordinate to obtain a standard curve;
(3) detection of sample to be tested
Respectively adding a sample to be detected to 50 mu L into corresponding holes of an ELISA plate coated with an anti-S100B monoclonal antibody, then adding a horseradish peroxidase-labeled detection anti-S100 polyclonal antibody solution to 100 mu L, and lightly oscillating and uniformly mixing;
sealing the plate with a sealing plate film, then incubating for 2 hours at 37 ℃, fully washing for 5 times with the washing solution, and drying;
adding 25 mu L of luminous liquid A, B liquid respectively, and lightly shaking and uniformly mixing;
adjusting the zero point by using a blank hole, and measuring the optical density value by using a luminometer;
and substituting the optical density value of the sample solution to be detected into the standard curve to obtain the content of S100B in the sample solution to be detected.
According to the kit provided by the embodiment of the invention, the reaction time of the anti-S100 polyclonal antibody solution for detecting the horseradish peroxidase label of the to-be-detected substance (standard substance or serum sample) is 2 hours; the clinical common pathological jaundice and lipemia specimens have no obvious interference on the determination of the serum S100B protein; the average variation in batch and between batches is less than 5.0 percent, and the method has the technical effects of simplicity, convenience, rapidness, specificity, sensitivity and suitability for clinical routine application.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention is described in further detail below with reference to the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
The chemiluminescence detection kit for the S100B protein provided by the embodiment of the invention comprises: the kit comprises an ELISA plate coated with an anti-S100B monoclonal antibody, an anti-S100 polyclonal antibody solution for detecting horseradish peroxidase labeling, a standard product diluent, a sample diluent, a concentrated washing solution, a luminescent solution A, a luminescent solution B and a detection antibody diluent.
In the embodiment of the invention, the anti-S100 polyclonal antibody solution for detecting the horseradish peroxidase marker is prepared by purifying and quantifying the antibody, dialyzing the antibody in a carbonate buffer solution with the pH of 9.0-9.5 and the concentration of 0.01 mol/L to 5mg/m L, preparing a horseradish peroxidase aqueous solution with the concentration of 5mg/m L, and adding NaIO (sodium iodide oxide) with the concentration of 37.5mg/m L into the horseradish peroxidase aqueous solution with the concentration of 0.4m L4Stirring at room temperature in dark for 20min to obtain oxidized enzyme solution, dialyzing the oxidized enzyme solution in acetate buffer solution of 1 mmol/L, pH 4.4 and 4 deg.C overnight, changing solution for 3 times, collecting the solution in dialysis bag, adding 0.2 mol/L Na2CO3Adjusting the pH of the buffer solution to 9.0-9.5, quickly mixing the buffer solution with purified and quantified antibody 1:1, slightly stirring the mixture for 2 hours at room temperature in a dark place, adding 100ul of L NaBH4 solution at 6mg/m, uniformly mixing, reacting for 2 hours at 4 ℃, dialyzing the reduced reaction system in PBS (0.15 mol/L and pH 7.4) at 4 ℃ overnight, changing the solution for 3 times, adding BSA (bovine serum albumin) until the final concentration is 2-3 mg/m L, uniformly mixing, × 3 minutes at 10000rpm, collecting supernatant, subpackaging and freezing.
In the present example, the standard is the S100B antigen.
In the present example, the solvent of the sample diluent is a phosphate buffered saline solution with 20 mmol/L and pH 6.0, and the solute and its mass concentration in the sample diluent are 0.2% gelatin, 0.2% casein, 150 mmol/L NaCl, 0.01% Tween-20, 5% sucrose, 0.5/ten thousand bromopotassium phenol violet, and 0.1% preservative.
In the embodiment of the invention, the solvent of the concentrated washing solution is water, and the solute and Na with the concentration of 116 g/L in the concentrated washing solution are2HPO4·12H2O、11.84g/L NaH2PO42H2O, 180 g/L NaCl, 5m L/L Tween 20 and 1m L/L preservative.
In the embodiment of the invention, the solvent of the luminescent liquid A is Tris-HCl buffer solution with pH of 8.0 and 0.2 mol/L, the solute and the concentration of the solute in the luminescent liquid A are 3mg/m L of luminol, 0.25mg/m L of p-iodophenol and 0.5mg/m L of sodium tetraphenylborate;
in the embodiment of the invention, the solvent of the luminescent liquid B is Tris-HCl buffer solution with the pH value of 8.0 and 0.2 mol/L, and the solute and carbamide peroxide with the concentration of 0.5mg/m L in the luminescent liquid B are used as solutes.
In the embodiment of the invention, the solvent of the standard dilution is a phosphate buffered saline solution with 20 mmol/L and pH7.4, the solute and the concentration thereof in the standard dilution are casein with the mass percentage of 1%, trehalose with the mass percentage of 8%, mannitol with the mass percentage of 3%, EDTA with the mass percentage of 1 mmol/L, glycine with the mass percentage of 0.5%, NaCl with the mass percentage of 150 mmol/L and preservative with the mass percentage of 0.1%.
In the embodiment of the present invention, the solvent of the test antibody diluent is a phosphate buffered saline solution with a pH of 7.4 of 20 mmol/L, and the solute and the concentration thereof in the test antibody diluent are bovine serum albumin with a mass percentage of 2%, casein with a mass percentage of 0.1%, NaCl with a mass percentage of 150 mmol/L, tween 20 with a mass percentage of 0.01%, aminopyrine with a mass percentage of 5/1 ten thousand, dye with a mass percentage of 1/20 ten thousand, and preservative with a mass percentage of 0.1%.
As follows, the embodiment of the present invention provides a method for drawing a standard curve, in which an Optical Density (OD) value of a sample solution to be measured is substituted into the standard curve, so as to obtain a content of S100B in the sample solution to be measured.
(1) The following solutions were prepared:
diluting a detection anti-S100 polyclonal antibody solution marked by horseradish peroxidase by using a detection antibody diluent, wherein the ratio of the detection anti-S100 polyclonal antibody solution marked by horseradish peroxidase to the detection antibody diluent is 1: 10000;
diluting a detection anti-S100 polyclonal antibody solution marked by horseradish peroxidase by using a detection antibody diluent, wherein the volume ratio of the detection anti-S100 polyclonal antibody marked by the horseradish peroxidase to the detection antibody diluent is 1:5000, so as to obtain an enzyme conjugate;
dissolving the standard substance by using the standard substance diluent to obtain standard substance solutions with the concentrations of 0pg/m L, 10pg/m L, 100pg/m L, 200pg/m L, 500pg/m L and 1000pg/m L respectively;
and diluting the concentrated washing solution with distilled water or deionized water according to the volume ratio of 1:20 to obtain the washing solution.
(2) Drawing a standard curve:
respectively adding 50 mu L of calibrator solution into corresponding holes of an ELISA plate coated with the anti-S100B monoclonal antibody, then respectively adding 100 mu L of horseradish peroxidase-labeled anti-S100 polyclonal antibody solution for detection into each hole, and lightly shaking and uniformly mixing;
sealing the plate with a sealing plate film, then incubating for 2 hours at 37 ℃, fully washing for 5 times with the washing solution, and drying;
adding 25 mu L of luminous liquid A, B into each hole, and lightly shaking and uniformly mixing;
adjusting the zero point by using a blank hole, and measuring the optical density value of each hole by using a luminometer;
performing data processing by using a log-log linear fitting mode, and drawing by using the log of the optical density value of each calibrator as a vertical coordinate and the log of the concentration of each calibrator as a horizontal coordinate to obtain a standard curve; as shown in fig. 1, the equation of the standard curve is 0.8818x +3.6761, and the correlation coefficient is 0.9995.
As follows, the embodiment of the present invention further provides a method for detecting the content of S100B in a sample solution to be detected.
Respectively adding a sample to be detected to 50 mu L into corresponding holes of an ELISA plate coated with an anti-S100B monoclonal antibody, then adding a horseradish peroxidase-labeled detection anti-S100 polyclonal antibody solution to 100 mu L, and lightly oscillating and uniformly mixing;
sealing the plate with a sealing plate film, then incubating for 2 hours at 37 ℃, fully washing for 5 times with the washing solution, and drying;
adding 25 mu L of luminous liquid A, B liquid respectively, and lightly shaking and uniformly mixing;
adjusting the zero point by using a blank hole, and measuring the optical density value by using a luminometer;
and substituting the optical density value of the sample solution to be detected into the standard curve to obtain the content of S100B in the sample solution to be detected.
The kits provided in the examples of the present invention were subjected to performance tests by the following methods. And respectively selecting three batches of kits, namely a batch one, a batch two and a batch three, and carrying out performance test.
Firstly, the method comprises the following steps: minimum limit of detection
Adding 50 mu L standard substance into each hole of an ELISA plate coated with an anti-S100B monoclonal antibody, then adding 100 mu L of an anti-S100 polyclonal antibody solution for detection labeled by horseradish peroxidase into each hole, incubating at 37 ℃ for 2 hours, fully washing for 5 times by using a washing solution, draining, adding 25 mu L luminescent solution A and 25 mu L luminescent solution B into each hole, and measuring the luminescent value of each hole by using a luminometer.
Wherein, each kit to be tested, the blank standard substance solution is provided with 20 compound holes, other standard substances are provided with double holes, the light absorption value of each hole is shown in table 1, and the light emitting value of each hole is shown in table 1.
Calculating the Mean value (Mean) and Standard Deviation (SD) of the corresponding luminescence values of the 50 mu L S0 solution of the 20 holes, and calculating the concentration value of the luminescence value of Mean +2 × SD as the lowest detection limit by a fitting equation.
The lowest detection limit of the three batches of kits is below 1pg/m L.
Table 1:
II, secondly: repeatability and lot-to-lot difference
The repeatability is the Coefficient of Variation (CV) obtained by measuring a sample by using the same batch of kit, each standard sample needs to be subjected to 10-hole precision measurement randomly in one plate, the average concentration (Mean) and the Standard Deviation (SD) of the measurement result are calculated, and the Coefficient of Variation (CV) in the batch is SD/Mean × 100%
The batch difference is the repeatability among different batches of kits, three batches of kits are randomly drawn, the standard substance is measured for 3 times by using the kits, the average concentration (Mean) and the Standard Deviation (SD) of the measurement result are calculated, the batch variation Coefficient (CV) is SD/Mean × 100% 100, and the standard substance is S100B.
The specific detection process is as follows:
adding 50 mu L specific solution into each well of an ELISA plate coated with an anti-S100B monoclonal antibody, then adding 100 mu L enzyme conjugate into each well, incubating for 2 hours at 37 ℃, fully washing for 5 times by using washing liquid, drying, adding 25 mu L luminescent liquid A and 25 mu L luminescent liquid B into each well, and measuring the luminescent value of each well by using a luminometer.
The specific solution is a specific solution A or a specific solution B.
The specific solution A is an S0 solution (the concentration of a standard is 0pg/m L), an S1 solution (the concentration of the standard is 10pg/m L), an S2 solution (the concentration of the standard is 100pg/m L), an S3 solution (the concentration of the standard is 200pg/m L), an S4 solution (the concentration of the standard is 500pg/m L) and an S5 solution (the concentration of the standard is 1000pg/m L).
The specific solution B is a standard solution with different concentration from the specific solution A.
The standard solution is prepared by dissolving the standard in 20mM PBS buffer (pH7.4) to obtain 100 pg/L low-concentration standard solution (QC1) and 600 pg/L high-concentration standard solution (QC2), and each specific solution B is provided with 10 multiple wells for each test kit.
The luminescence values of the wells with the particular solution A are shown in Table 2.
Table 2:
the luminescence values of the wells with the particular solution B are shown in Table 3.
Table 3:
| QC1 | QC2 | QC1 | QC2 | QC1 | QC2 |
| multiple holes 1 | 375825 | 1375935 | 374710 | 1371970 | 375340 | 1378860 |
| Multiple holes 2 | 375620 | 1373630 | 372290 | 1375895 | 374375 | 1373295 |
| Multiple holes 3 | 374730 | 1378095 | 374905 | 1372460 | 375390 | 1370585 |
| Multiple holes 4 | 367990 | 1377205 | 373930 | 1373390 | 375345 | 1372340 |
| Multiple holes 5 | 368125 | 1377525 | 373540 | 1376960 | 371805 | 1378965 |
| Multiple holes 6 | 369625 | 1375510 | 371110 | 1372490 | 375940 | 1374120 |
| Multiple holes 7 | 376525 | 1372685 | 372700 | 1376720 | 373930 | 1378440 |
| Multiple holes 8 | 369915 | 1378400 | 375335 | 1370655 | 376070 | 1376705 |
| Multiple holes 9 | 374190 | 1372405 | 373235 | 1373610 | 372190 | 1373470 |
| Multiple holes 10 | 370595 | 1374980 | 375795 | 1372515 | 375755 | 1370730 |
The data was processed using a log-log linear fit to calculate the concentration of S100B in a particular solution b from the standard curve, and the results are shown in tables 4 and 5. The three batches of the kit are used for measuring two quality controls of high concentration and low concentration, and the variation coefficient in the batch is less than 5 percent, which shows that the kit has good uniformity and repeatability of results.
Table 4:
table 5:
| QC1 | QC2 |
| first batch | 135.42 | 618.40 |
| Second batch | 138.81 | 617.96 |
| Third batch | 140.30 | 617.99 |
| Mean value of | 138.18 | 618.12 |
| SD | 2.501 | 0.246 |
| CV | 1.81% | 0.04% |
Three batches of kits are used for measuring two standard products with high concentration and low concentration, and the batch-to-batch variation coefficient is less than 5 percent, which shows that the kits in different batches have small variation and the measurement result has repeatability.
In summary, the main performance indexes of the kit provided by the invention have the following standards:
the lowest detection limit is not higher than 1pg/m L;
repeatability: the intra-batch variation coefficient is not higher than 5%;
inter-batch difference: the inter-batch coefficient of variation is not higher than 5%.
Third, specificity
Adding 50 mu L specific solution into each hole of an ELISA plate coated with an anti-S100B monoclonal antibody, then adding 100 mu L anti-S100 polyclonal antibody solution for detection labeled by horseradish peroxidase into each hole, incubating at 37 ℃ for 30 minutes, fully washing for 5 times by using a washing solution, drying, adding 25 mu L luminescent solution A and 25 mu L luminescent solution B into each hole, and measuring the luminescent value of each hole by using a luminometer.
The specific solutions were S0 solution (concentration of standard was 0pg/m L), S1 solution (concentration of standard was 10pg/m L), S2 solution (concentration of standard was 100pg/m L), S3 solution (concentration of standard was 200pg/m L), S4 solution (concentration of standard was 500pg/m L), S5 solution (concentration of standard was 1000pg/m L), sample solution with serum total bilirubin TBI L of 40. mu. mol/L, and sample solution with triglyceride TG of 4 mmol/L and total cholesterol TC of 9 mmol/L.
L og-L og fitting is carried out according to the luminescence value of each calibration point and the corresponding concentration, and the S100B measured value of each cross-reaction substance is calculated according to a standard curve, wherein the concentration is the intersection value of the reagent and TBI L and the intersection value of the reagent and TG and TC.
The luminescence and the back-concentration of each well are shown in Table 6.
Table 6:
the specificity is to detect the interference of other substances in blood to the measurement of the kit, and the substances which easily interfere with the measurement of S100B in human blood are serum total bilirubin TBI L and triglyceride TG and total cholesterol TC., and the test is carried out with these substances in high concentrations, and referring to tables 6 and 7, the cross-reaction of the kit with these substances is low, and the measurement of S100B is not interfered.
Table 7:
fourthly, the method comprises the following steps: for diagnosis of craniocerebral injury
Clinical samples were collected from hospitals, 100 parts of healthy human serum and 48 parts of craniocerebral injury patient serum 12 hours after injury were collected, and the content of S100B in each serum sample was measured by an S100B quantitative determination kit (enzyme-linked immunosorbent assay), as shown in table 8.
Table 8:
the reference value range of the Mean plus 2 standard deviations Mean + -2 SD is 140-380 pg/m L.
In summary, in the kit provided by the embodiment of the present invention, the reaction time between the sample to be detected (the standard sample or the serum sample) and the horseradish peroxidase-labeled detection anti-S100 polyclonal antibody solution is 2 hours; the clinical common pathological jaundice and lipemia specimens have no obvious interference on the determination of the serum S100B protein; the average variation in batch and between batches is less than 5.0 percent, and the method has the technical effects of simplicity, convenience, rapidness, specificity, sensitivity and suitability for clinical routine application.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents and improvements made within the spirit and principle of the present invention are intended to be included within the scope of the present invention.